Ali Hakan Kaya

Specializzazione: Hematologist
20 anni di esperienza
Lingue parlate:
English
Studio medico: Turchia, Istanbul, Biruni University Hospital
Won First Prize for a paper from the Blood and Bone Marrow Transplantation Association in 2017.
Dr. Ali Hakan Kaya is a hematologist at Biruni University Hospital in Istanbul. He won first prize from the Blood and Bone Marrow Transplantation Association for his research. Dr. Kaya specializes in stem cell transplants and treating complex blood cancers. He works at a TEMOS-accredited university hospital equipped with a dedicated hematology-oncology department.
- Performs allogeneic bone marrow transplants from both related and unrelated donors.
- Treats leukemia, myeloma, and various types of lymphoma using CAR T-cell therapy.
- Is a member of the Turkish Apheresis Society and the Hematologic Oncology Society.
- Received multiple awards for his scientific papers on hematologic immunology and oncology.

Servizi medici

Vedi altro

Com'è andata la tua esperienza?

1 di 3

Le informazioni su questo medico sono complete e chiare

Totalmente in disaccordo

Totalmente d'accordo

Formazione accademica

Dr. Ali Hakan Kaya is an Associate Professor specializing in hematology and stem cell transplantation at Biruni University Hospital. He won First Prize from the Blood and Bone Marrow Transplantation Association in 2017. Dr. Kaya holds multiple awards for his scientific research in hematologic oncology and immunology.

Specialization and Hematologic Care

Dr. Kaya treats adult blood cancers and disorders. He performs bone marrow and stem cell transplantations. These procedures include allogenic transplants from both related and unrelated donors. He also uses haploidentical techniques to expand donor options for patients.

The doctor treats various conditions:

Leukemia (AML and ALL)
Multiple Myeloma
Hodgkin's and Non-Hodgkin's lymphoma
Burkitt's and Follicular lymphoma
Aplastic anemia
Thrombocytopenia

Dr. Kaya uses CAR T-cell therapy for advanced cases. CAR T-cell therapy is a treatment where a patient's immune cells are reprogrammed to attack cancer. He also provides chemotherapy and biological therapy protocols. As part of his diagnostic work, he performs bone marrow biopsies and immunohistochemistry.

Work Experience

2022–2024 – Associate Professor, Istanbul VM Medical Park Pendik Hospital
2021–2024 – Associate Professor, Maltepe University Faculty of Medicine
2019–2021 – Associate Professor, Istanbul Ümraniye Training and Research Hospital
2018–2019 – Hematology Subspecialist, Istanbul Ümraniye Training and Research Hospital
2017–2018 – Hematology Subspecialist, Ankara Gülhane Training and Research Hospital
2013–2017 – Subspecialty Training, Ankara Oncology Training and Research Hospital
2012–2013 – Internal Medicine Specialist, Samsun Military Hospital
2010–2012 – Internal Medicine Specialist, Istanbul Esenyurt State Hospital
2006–2010 – Assistant Doctor, Istanbul Haseki Training and Research Hospital

Education and Training

2019 – Earned Associate Professor title at Istanbul Ümraniye Training and Research Hospital
2017 – Completed Hematology Subspecialty at Ankara Oncology Training and Research Hospital
2010 – Completed Internal Medicine Residency at Istanbul Haseki Training and Research Hospital
2005 – Graduated from Cerrahpaşa Faculty of Medicine, Istanbul University

Scientific Recognition and Awards

Dr. Kaya has received several national honors for his scientific papers:

2017 – First Prize, Blood and Bone Marrow Transplantation Association
2016 – Second Prize, Hematologic Oncology Society
2016 – Second Prize, Hematologic Immunology Association
2016 – Third Prize, Turkish Apheresis Association
2015 – Second Prize, Hematologic Oncology Society

Professional Memberships

Turkish Medical Association
Turkish Apheresis Society
Hematologic Oncology Society
Blood and Bone Marrow Transplant Association
Hematologic Immunology Society